Pharmac ApS: Financial statements 2023
CVR: 38532529
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmac ApS (CVR 38532529) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,901,902 and a net result of DKK 409,686 compared with DKK 964,114 the year before. That is a decrease of 22.1% compared with the year before. Equity in the 2023 report amounted to DKK 4,006,884. The solvency ratio was 84.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,901,902
- Profit/Loss
- DKK 409,686
- Equity
- DKK 4,006,884
- Total Assets
- DKK 4,753,718
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.9 mio. | 410 t. | 4 mio. | 2 |
| 2022 | - | 3.7 mio. | 964 t. | 3.6 mio. | 2 |
| 2021 | - | 3.4 mio. | 875 t. | 2.6 mio. | 2 |
| 2020 | - | 3 mio. | 577 t. | 1.8 mio. | 2 |
| 2019 | - | 3.5 mio. | 1.1 mio. | 3.2 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmac ApS has published its annual report for 2022. Gross profit came to DKK 3,726,051, and the net result was DKK 964,114.
About Pharmac ApS
Pharmac ApS is a Danish company of the type Anpartsselskab based in Lille Skensved, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mads Friis Sørensen. The company is owned by AC Holding, LS ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 3,203,639 and a net result of DKK 678,530 compared with DKK 828,872 the year before. Equity in the 2025 report amounted to DKK 5,514,286.